These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3182096)

  • 1. Ciprofloxacin in combination with metronidazole.
    Werk R; Schneider L
    Infection; 1988; 16(4):257-60. PubMed ID: 3182096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole.
    Heizmann WR; Schmid R; Heilmann F; Werner H
    Infection; 1989; 17(3):160-4. PubMed ID: 2737759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
    Klietmann W; Focht J; Nösner K
    Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of spiramycin and metronidazole alone or in combination against clinical isolates from odontogenic abscesses.
    Roche Y; Yoshimori RN
    J Antimicrob Chemother; 1997 Sep; 40(3):353-7. PubMed ID: 9338486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.
    Fernandes PB; Chu DT; Swanson RN; Ramer NR; Hanson CW; Bower RR; Stamm JM; Hardy DJ
    Antimicrob Agents Chemother; 1988 Jan; 32(1):27-32. PubMed ID: 3348609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.
    Heizmann WR; Heilmann F; Egeler B; Werner H
    Infection; 1990; 18(2):117-21. PubMed ID: 2332245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.
    Boeckh M; Lode H; Deppermann KM; Grineisen S; Shokry F; Held R; Wernicke K; Koeppe P; Wagner J; Krasemann C
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2407-14. PubMed ID: 2088195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility of bacteria isolated from clinical material to ciprofloxacin].
    Namysł E; Galiński J; Szponar M; Piechowicz L
    Med Dosw Mikrobiol; 1995; 47(1-2):5-9. PubMed ID: 8523970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of the new oral cephalosporin Bay v 3522 against aerobic and anaerobic bacteria.
    Rylander M; Nord CE; Norrby SR
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):777-82. PubMed ID: 2261923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W; Chylak J; Pietkiewicz K
    Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria.
    Rylander M; Nord CE; Norrby SR
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):919-24. PubMed ID: 2512142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
    King A; Bethune L; Phillips I
    J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species.
    Marchese A; Salerno A; Pesce A; Debbia EA; Schito GC
    Chemotherapy; 2000; 46(4):253-66. PubMed ID: 10859431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Common pathogens of surgical infections and their drug sensitivities].
    Zhang YP
    Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):215-6, 253. PubMed ID: 2805989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro activity of the combination of daptomycin and metronidazole against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus spp., and Bacteroides spp.
    Werner H; Nagy E; Heizmann WR
    J Chemother; 1989 Jul; 1(4 Suppl):207-8. PubMed ID: 16312371
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
    Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
    Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of dactimicin against aerobic and anaerobic bacteria isolated from intra-abdominal infections.
    Nord CE; Kager L
    Drugs Exp Clin Res; 1989; 15(3):113-4. PubMed ID: 2752908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscesses.
    Pefanis A; Thauvin-Eliopoulos C; Holden J; Eliopoulos GM; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1994 Feb; 38(2):252-5. PubMed ID: 8192453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
    Gosselink MP; Schouten WR; van Lieshout LM; Hop WC; Laman JD; Ruseler-van Embden JG
    Dis Colon Rectum; 2004 Sep; 47(9):1519-25. PubMed ID: 15486751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.